Edgewise Therapeutics, Inc.
EWTXBiotechnology
$38.91−3.90%As of Oct 29vs prior close
- Market cap
- $4.2B
- P/E (TTM)
- –
- P/E (FY1)
- 28.2×
- From 52W high
- −19.52%
- EPS (LTM)
- -$1.85
- Dividend yield
- 0.00%
Nomior Score
63
Steady ProfileTop 21% of the scored universe
Growth—
Quality46
Value54
Momentum96
Resilience45